{"id":5713,"date":"2024-10-31T15:29:48","date_gmt":"2024-10-31T12:29:48","guid":{"rendered":"https:\/\/rvc.com.sa\/?p=5713"},"modified":"2024-10-31T15:29:48","modified_gmt":"2024-10-31T12:29:48","slug":"acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund","status":"publish","type":"post","link":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/","title":{"rendered":"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund"},"content":{"rendered":"

Dr. Falk Pharma announced its acquisition of Kynos Therapeutics, one of Riyadh Valley Company’s investments, through the British Epidarex Fund on October 29, 2024.<\/span><\/p>\n

Kynos Therapeutics was founded by Dr. Damian Mole and Dr. Scott Webster. It is a biotechnology company focused on developing new inhibitors as an innovative therapeutic approach for acute and chronic inflammatory diseases. This has attracted the attention of Dr. Falk Pharma, a German company that has specialized in the development and marketing of innovative medicines for over 60 years.<\/span><\/p>\n

In this regard, Dr. Khalid bin Saad Al-Saleh, CEO of Riyadh Valley Company, commented, “Kynos Therapeutics is one of the portfolio companies through the Epidarex Fund of Riyadh Valley Company \u2013 the investment arm of King Saud University \u2013 which enables this acquisition to continue the efforts of providing a new generation of innovative treatments for acute and chronic inflammatory diseases.”<\/span><\/p>\n

This acquisition supports the objectives of Riyadh Valley Company \u2013 the investment arm of King Saud University \u2013 to achieve Saudi Vision 2030 through a balanced investment strategy that leverages local capabilities. The company invests both locally and internationally in early-stage and growth-phase companies to generate financial returns and strategic outcomes that contribute to the growth and development of the knowledge-based economy in Saudi Arabia.<\/span><\/p>\n

For more information:<\/span><\/p>\n

https:\/\/epidarex.com\/dr-falk-pharma-acquires-spinout-kynos-therapeutics-to-develop-its-novel-kmo-inhibitors-for-acute-pancreatitis\/<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Dr. Falk Pharma announced its acquisition of Kynos Therapeutics, one of Riyadh Valley Company’s investments, through the British Epidarex Fund on October 29, 2024. Kynos Therapeutics was founded by Dr. Damian Mole and Dr. Scott Webster. It is a biotechnology company focused on developing new inhibitors as an innovative therapeutic approach for acute and chronic…<\/p>\n","protected":false},"author":5,"featured_media":5711,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[36],"tags":[],"class_list":["post-5713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\nAcquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund - \u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund - \u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636\" \/>\n<meta property=\"og:description\" content=\"Dr. Falk Pharma announced its acquisition of Kynos Therapeutics, one of Riyadh Valley Company’s investments, through the British Epidarex Fund on October 29, 2024. Kynos Therapeutics was founded by Dr. Damian Mole and Dr. Scott Webster. It is a biotechnology company focused on developing new inhibitors as an innovative therapeutic approach for acute and chronic...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/\" \/>\n<meta property=\"og:site_name\" content=\"\u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-31T12:29:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvc.com.sa\/wp-content\/uploads\/2024\/10\/\u0642\u0627\u0644\u0628-\u0627\u0644\u0623\u062e\u0628\u0627\u0631-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"RVC\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@riyadhvalley\" \/>\n<meta name=\"twitter:site\" content=\"@riyadhvalley\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"RVC\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/\"},\"author\":{\"name\":\"RVC\",\"@id\":\"https:\/\/rvc.com.sa\/#\/schema\/person\/1259412aa4c1a858d92ab8480ba5deac\"},\"headline\":\"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund\",\"datePublished\":\"2024-10-31T12:29:48+00:00\",\"dateModified\":\"2024-10-31T12:29:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/rvc.com.sa\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/\",\"url\":\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/\",\"name\":\"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund - \u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636\",\"isPartOf\":{\"@id\":\"https:\/\/rvc.com.sa\/#website\"},\"datePublished\":\"2024-10-31T12:29:48+00:00\",\"dateModified\":\"2024-10-31T12:29:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/rvc.com.sa\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvc.com.sa\/#website\",\"url\":\"https:\/\/rvc.com.sa\/\",\"name\":\"\u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/rvc.com.sa\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvc.com.sa\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvc.com.sa\/#organization\",\"name\":\"\u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636\",\"url\":\"https:\/\/rvc.com.sa\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/rvc.com.sa\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvc.com.sa\/wp-content\/uploads\/2020\/08\/Logo.svg\",\"contentUrl\":\"https:\/\/rvc.com.sa\/wp-content\/uploads\/2020\/08\/Logo.svg\",\"width\":175,\"height\":60,\"caption\":\"\u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636\"},\"image\":{\"@id\":\"https:\/\/rvc.com.sa\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/twitter.com\/riyadhvalley\",\"https:\/\/www.linkedin.com\/company\/riyadh-valley-company-rvc-\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvc.com.sa\/#\/schema\/person\/1259412aa4c1a858d92ab8480ba5deac\",\"name\":\"RVC\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/rvc.com.sa\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3fbfdb8dac50a0bb4d6d79e0e748f5de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3fbfdb8dac50a0bb4d6d79e0e748f5de?s=96&d=mm&r=g\",\"caption\":\"RVC\"},\"url\":\"https:\/\/rvc.com.sa\/en\/author\/marwah\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund - \u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/","og_locale":"en_US","og_type":"article","og_title":"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund - \u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636","og_description":"Dr. Falk Pharma announced its acquisition of Kynos Therapeutics, one of Riyadh Valley Company’s investments, through the British Epidarex Fund on October 29, 2024. Kynos Therapeutics was founded by Dr. Damian Mole and Dr. Scott Webster. It is a biotechnology company focused on developing new inhibitors as an innovative therapeutic approach for acute and chronic...","og_url":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/","og_site_name":"\u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636","article_published_time":"2024-10-31T12:29:48+00:00","og_image":[{"width":1200,"height":500,"url":"https:\/\/rvc.com.sa\/wp-content\/uploads\/2024\/10\/\u0642\u0627\u0644\u0628-\u0627\u0644\u0623\u062e\u0628\u0627\u0631-2.png","type":"image\/png"}],"author":"RVC","twitter_card":"summary_large_image","twitter_creator":"@riyadhvalley","twitter_site":"@riyadhvalley","twitter_misc":{"Written by":"RVC","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/#article","isPartOf":{"@id":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/"},"author":{"name":"RVC","@id":"https:\/\/rvc.com.sa\/#\/schema\/person\/1259412aa4c1a858d92ab8480ba5deac"},"headline":"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund","datePublished":"2024-10-31T12:29:48+00:00","dateModified":"2024-10-31T12:29:48+00:00","mainEntityOfPage":{"@id":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/rvc.com.sa\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/","url":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/","name":"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund - \u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636","isPartOf":{"@id":"https:\/\/rvc.com.sa\/#website"},"datePublished":"2024-10-31T12:29:48+00:00","dateModified":"2024-10-31T12:29:48+00:00","breadcrumb":{"@id":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/rvc.com.sa\/en\/acquisition-of-kynos-by-dr-falk-pharma-an-investment-by-riyadh-valley-company-through-the-british-epidarex-fund\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rvc.com.sa\/en\/"},{"@type":"ListItem","position":2,"name":"Acquisition of Kynos by Dr. Falk Pharma: An Investment by Riyadh Valley Company through the British Epidarex Fund"}]},{"@type":"WebSite","@id":"https:\/\/rvc.com.sa\/#website","url":"https:\/\/rvc.com.sa\/","name":"\u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636","description":"","publisher":{"@id":"https:\/\/rvc.com.sa\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvc.com.sa\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/rvc.com.sa\/#organization","name":"\u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636","url":"https:\/\/rvc.com.sa\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/rvc.com.sa\/#\/schema\/logo\/image\/","url":"https:\/\/rvc.com.sa\/wp-content\/uploads\/2020\/08\/Logo.svg","contentUrl":"https:\/\/rvc.com.sa\/wp-content\/uploads\/2020\/08\/Logo.svg","width":175,"height":60,"caption":"\u0634\u0631\u0643\u0629 \u0648\u0627\u062f\u064a \u0627\u0644\u0631\u064a\u0627\u0636"},"image":{"@id":"https:\/\/rvc.com.sa\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/twitter.com\/riyadhvalley","https:\/\/www.linkedin.com\/company\/riyadh-valley-company-rvc-\/"]},{"@type":"Person","@id":"https:\/\/rvc.com.sa\/#\/schema\/person\/1259412aa4c1a858d92ab8480ba5deac","name":"RVC","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/rvc.com.sa\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3fbfdb8dac50a0bb4d6d79e0e748f5de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3fbfdb8dac50a0bb4d6d79e0e748f5de?s=96&d=mm&r=g","caption":"RVC"},"url":"https:\/\/rvc.com.sa\/en\/author\/marwah\/"}]}},"_links":{"self":[{"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/posts\/5713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/comments?post=5713"}],"version-history":[{"count":1,"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/posts\/5713\/revisions"}],"predecessor-version":[{"id":5714,"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/posts\/5713\/revisions\/5714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/media\/5711"}],"wp:attachment":[{"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/media?parent=5713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/categories?post=5713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvc.com.sa\/en\/wp-json\/wp\/v2\/tags?post=5713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}